NEW YORK (GenomeWeb) – ArcherDx announced today that it has partnered with Germany-based Merck KGaA to develop and commercialize a next-generation sequencing-based companion diagnostic assay for one of the pharmaceutical company's drug candidates.
NEW YORK (GenomeWeb) – ArcherDx announced today that it has partnered with Germany-based Merck KGaA to develop and commercialize a next-generation sequencing-based companion diagnostic assay for one of the pharmaceutical company's drug candidates.
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.
Don't have a 360Dx or GenomeWeb account?
Register for Free.